WALLnut
12 hours ago
FDA is getting that much needed makeover—and not just cosmetically. The agency just announced a push to fast-track antibody therapies using more human-relevant testing, cutting down on delays without sacrificing safety. It’s a major shift, signaling the FDA’s intent to modernize its outdated approval framework and finally catch up with the pace of science.
This isn’t just about speed. It’s about smarter regulation. By working with groups like the NIH and the Department of Veterans Affairs, and through the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), the FDA is laying down a roadmap for a future built on innovation, not inertia.
Why does this matter for RadioGel? Because it proves the door is cracking open. Congress, scientists, and patients have all been calling for the FDA to move toward more human-relevant models—and that’s exactly where RadioGel shines. A precision-delivered, tumor-targeting device with safety data already in hand, it’s a prime candidate for this new regulatory era.
As Commissioner Makary put it, this change means a more efficient pipeline for treatments and a better chance at real-world outcomes—something RadioGel is built for. If the FDA’s serious about being a global leader in modern regulatory science, it’s time they back that up by supporting breakthrough therapies that are ready now.
$RDGL
WALLnut
12 hours ago
Looks like FDA is getting a much-needed makeover. For years, bureaucracy and outdated review models have stalled promising technologies like RadioGel from reaching patients who need them most. But the pressure is mounting—from patients, innovators, and now even from within.
Vivos Inc. isn’t just knocking at the door—they’re forcing it open with real science, safety data, and a device that fills a massive treatment gap. The FDA knows it’s time to evolve or get left behind. With this final IDE sprint and a company that refuses to quit, change might finally be coming—and not just for RadioGel, but for the entire system.
Let’s hope the FDA’s “makeover” means opening the path for innovation, accountability, and life-saving options.
$RDGL
Rum_Tequila
22 hours ago
.@DrMakaryFDA: “I cannot tell you how many lobbyists, former members of Congress - The Swamp - reached out to me. I was in the operating room, and the next day I discovered what The Swamp was... This is how it happens: ‘We want to help you with your confirmation. We want to write a letter on behalf of our company to the senators on your committee. We know these senators, we’re going to talk to them, if it’s okay with you.' You know what I said? ‘Don’t talk to the senators. I don’t want your letters. They’re not for free.’”
FULL show:
youtu.be/R4mojSYOTnQ
this guy is not for sale, he feels no obligation but to serve the health of the nation
chereb19
2 days ago
Recently, a friend of a friend mentioned that one of their relatives was interested in Radiogel. They came across that Investoshub nonsense about phase 1 being underdosed, and they genuinely weren’t sure what to believe. That hit home for me — it showed how damaging misinformation can be, especially to people who are seriously looking into the treatment.
We all have our own moral standards — some choose to sit back and let things play out, and that’s find. Others, like me, feel a responsibility to act when something feels wrong, especially when it could impact real lives. So I’m extremely passionate about fact-checking these lies. It’s not just FUD — it’s potentially dangerous, and I honestly believe it could cost lives if left unchallenged. That’s why I won’t stop calling it out.
doccjc
2 days ago
Some investors check message boards as part of their DD. One check of this one is going to chase a few away imo.
When he's not around, there is good discussion. When he appears,, it's an all out battle, discussing his bs. It's what he wants..
I'll probably hear the "put the bully in his place" argument.. All the bully cares about is that he has a means to continue to spread his bs/FUD.
And with a thinly traded stock, it doesn't take much to move the share price. We'll probably have a lot of new faces in the coming weeks/months. Hopefully they won't be reading the back and forth bs that has taken over the board.
doccjc
2 days ago
Here's the problem with responding and engaging the clown.. He's saying the world is flat,,,, and we start a discussion on why the world isn't flat. That becomes the topic of discussion. We all know the world isn't flat,,,he knows the world isn't flat. New investors come on and only see these discussions. Pure FUD. He only lives because he is engaged. Planting a seed of doubt. New investors don't like any doubt. Don't engage . He won't go away but he also won't be the topic of discussion. Right now thats all we see. back and forth with SC8. There is so much more to discuss then his bs/FUD. He's a little kid throwing a tantrum, and getting all the attention he needs to make his tantrum effective.. Just my opinion. He's probably not returning because the share price is getting slammed this morning. His job is done.
Be smart.. ignore the pos